GHG Emission Reductions With Industrial Biotechnology: Assessing the Opportunities

GHG Emission Reductions With Industrial Biotechnology: Assessing the Opportunities

Industrial Biotechnology, cleverly working with nature to meet human needs, can potentially play a significant part in the effort to reduce human impact on the environment. This report focuses on undertaking a first estimate of the GHG emission reductions that could be achieved, on a global scale, if the potential of sustainable biotechnologies is fully harvested. The report builds on input from Novozymes and other companies and experts from a variety of sectors and disciplines, which have been involved in the work, as well as WWF.

Nachrichten unserer Mitglieder

  • BSB würdigt Symrise-Produkte SymGuard® CD und SymControlTM Care mit Innovationspreis

    Symrise AG 6.08.2018Mehr
  • MyBio Adopts Genedata for Improving Antibiotic Production Processes

    Genedata GmbH10.07.2018Mehr
  • Klaus Pellengahr neuer Geschäftsführer bei Organobalance-Novozymes Berlin. Gründerin Prof. Dr. Christine Lang bleibt dem Unternehmen als Beraterin verbunden

    Organobalance GmbH 2.07.2018Mehr
  • Alle Links